

Oral Disintegrating and Dissolving Film Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Oral Disintegrating and Dissolving Film market is expected to grow significantly in the coming years due to increasing demand for convenient and easy-to-administer pharmaceutical products. The market size is estimated to reach $1.5 billion by 2025, driven by advancements in drug delivery technology and rising prevalence of oral disorders.
Companies Covered (Covid 19 Impact Covered)
◍ Aquestive Therapeutics
◍ Kyukyu Pharmaceutical
◍ BioDelivery(BDSI)
◍ IntelGenx
◍ Tapemark
◍ Shilpa Therapeutics
◍ CL Pharm
◍ Lubrizol Life Science
◍ Adhex Pharma
◍ DK Livkon
◍ Arx Pharma
◍ Aavishkar
◍ ZIM Laboratories
◍ Umang Pharmaceuticals
◍ Cure Pharmaceutical
The Oral Disintegrating and Dissolving Film Market is highly competitive with companies like Aquestive Therapeutics, Kyukyu Pharmaceutical, IntelGenx, and others leading the market. These companies focus on innovation, partnerships, and product development to drive sales and revenue growth. Some sales revenue actual figures include: Aquestive Therapeutics - $80 million, BioDelivery (BDSI) - $50 million, IntelGenx - $30 million.
◍ Hospital and Clinic
◍ Drug Store
◍ E-commerce
◍ Orodispersible Film
◍ Oromucosal Film
Request Sample Report